Profile Of Childhood Measles Patients At Rsi Siti Rahmah Padang 2020-2022


  • Laura Zeffira Medical Faculty of Universitas Baiturrahmah, Padang, Sumatera Barat, Indonesia
  • Elfi Yulfienti Medical Faculty of Universitas Baiturrahmah, Padang, Sumatera Barat, Indonesia
  • Villya Yulika Bachelor Student of Medical Faculty of Universitas Baiturrahmah, Padang, Sumatera Barat, Indonesia
  • Kurnia Maidarmi Handayani Medical Faculty of Universitas Baiturrahmah, Padang, Sumatera Barat, Indonesia
  • Widia Sari Medical Faculty of Universitas Baiturrahmah, Padang, Sumatera Barat, Indonesia
  • Ghaniyyatul Khudri Medical Faculty of Universitas Baiturrahmah, Padang, Sumatera Barat, Indonesia



epidemiology, children, measles, Morbillivirus, vaccination


Measles (morbilli), caused by the Morbillivirus, is a highly contagious disease primarily affecting children under 15 years of age. The incidence of measles in Indonesia, particularly in West Sumatra, has been increasing due to declining vaccination coverage. This study provides a descriptive analysis of pediatric measles cases at RSI Siti Rahmah Hospital in Padang, using secondary data from medical records between March 2020 and August 2022. A total of 57 pediatric measles patients were identified. The majority of these patients were aged 5-9 years and predominantly female. Diagnoses were primarily made through anamnesis and physical examination. Most patients had a history of measles vaccination, and more than 50% had good nutritional status. Importantly, 71% of patients with complications had not received measles vaccination. These findings suggest that measles vaccination is likely effective in reducing the severity and complications of the disease in children, highlighting the critical need for maintaining high vaccination coverage to mitigate the impact of measles outbreaks.


Download data is not yet available.


Ariani, R., Puspita, R., Astuti, A. K. Y., Lestari, A. D., Dewi, A. S., & Open, M. K. M. (2024). Comparison Of Sars-Cov Antibody Titer Levels Against Abo Blood Type, Age, And Gender In Convalescent Plasma Donations. MSJ : Majority Science Journal, 2(1), 354–359.

BPS. (2020). Profil Kesehatan Provinsi Sumatera Barat 2020.

BPS. (2024). Persentase Balita yang Pernah Mendapat Imunisasi Campak (Persen), 2020-2022.

Datu, S. S., Angraeni, Fatwasari, F., Jarir, D. V., & Sabilah, A. A. (2024). Antibacterial Screening of Sargassum Sp Extract. Opposing Vibrio Parahaemolyticus Bacteria. MSJ : Majority Science Journal, 2(1), 288–295.

Farahdina, S., & Wulan, A. (2017). Morbili pada anak laki-laki usia 31 bulan dengan riwayat imunisasi campak pada usia 10 bulan. J Medula Unila, 7(1), 60–67.

Huvaid, S. U., Yulianita, & Mairoza, N. (2019). Faktor-faktor yang Berhubungan dengan Pemberian Imunisasi Campak pada Balita. Jurnal Riset Hesti Medan Akper Kesdam I/BB Medan, 4(2), 82–87.

Isu, A., Weraman, P., & Pucauly, I. (2016). Kajian Spasial Faktor Risiko Terjadinya Kejadian Luar Biasa Campak Dengan Geographical Information System. J MKMI, 12(4), 250–260.

Jamison, D., Feachem, R., & Makgoba, M. (2006). Vaccine-Preventable Diseases. In Disease and Mortality in Sub-Saharan Africa. 2nd edition.

Jensen, K., Søndergaard, M., & Andersen, A. (2014). A randomized trial of an early measles vaccine at 4 1/2 months of age in Guinea-Bissau: Sex-differential immunological effects. PLoS ONE, 9(5), 6–13.

Kementrian Kesehatan RI. (2018). Infodatin: Situasi Campak Dan Rubella Di Indonesia.

Kementrian Kesehatan RI. (2020). In Pedoman Surveilans Campak - Rubela.

Liwu, T., Rampengan, N., & Tatura, S. (2016). Hubungan Status Gizi Dengan Berat Ringannya Campak Pada Anak. E-CliniC, 4(2).

Marcdante, K., Kliegman, R., Jenson, H., & Behrman, R. (2014). Nelson Essentials of Pediatrics (6th Ed). Saunders Elsevier.

Maryati Sutarno, & Noka Ayu Putri Liana. (2019). Faktor-Faktor Yang Berhubungan Dengan Kejadian Ispa. Jurnal Antara Keperawatan, 2(2), 44–50.

Minta, A., Ferrari, M., & Antoni, S. (2023). Progress Toward Measles Elimination — Worldwide, 2000–2022. MMWR Morb Mortal Wkly Rep, 72, 1262–8.

Ngwa, C. H., Doungtsop, B.-C. K., Bihnwi, R., Ngo, N. V., & Yang, N. M. (2022). Burden of vaccine-preventable diseases, trends in vaccine coverage and current challenges in the implementation of the expanded program on immunization: A situation analysis of Cameroon. Human Vaccines & Immunotherapeutics, 18(1), 1939620.


Onyiriuka, A. (2011). Clinical profile of children presenting with measles in a Nigerian secondary health-care institution. J Infect Dis Immun., 3(6), 112–116.

Perrone, O., & Meissner, H. C. (2020). The Importance of MMR Immunization in the United States. 146(2), 1–6.

Sari, R., & Daramuseng, A. (2020). Hubungan Jenis Kelamin Dan Status Imunisasi Dengan Kejadian Campak PadaBalita Di Wilayah Kerja Puskesmas Palaran. Borneo Student Res, 1(3), 1937–1941.

Serres, G., Boulinanne, N., & Defay, F. (2012). Higher Risk of Measles When the First Dose of a 2-Dose Schedule ofMeasles Vaccine Is Given at 12 – 14 Months Versus 15 Months of Age. Clin Infect Dis, 3(6), 394–402.

Shet, A., Carr, K., Danovaro-Holliday, M. C., Sodha, S. V, Prosperi, C., Wunderlich, J., Wonodi, C., Reynolds, H. W., Mirza, I., Gacic-Dobo, M., O’Brien, K. L., & Lindstrand, A. (2022). Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories. The Lancet Global Health, 10(2), e186–e194.




How to Cite

Zeffira, L., Yulfienti, E., Yulika, V., Handayani, K. M., Sari, W., & Khudri, G. (2024). Profile Of Childhood Measles Patients At Rsi Siti Rahmah Padang 2020-2022. MSJ : Majority Science Journal, 2(2), 47–51.